Once that happens-- volume will pour in and smooth sailing to $7.00. I however, am buying on the development of it microRNA-based diagnostic tools-- this tiny company is making headlines in the scientific community for its cutting edge research. Easy buyout at even $20 is still cheap on a valuation basis. I don't see any downside risk with ROSG, funding in place, easy buy on the long side. Just buy and hold-- good things to come.